// App-Quantinova.ai

3904 : Overcoming resistance to HER2 inhibitors through cell based screening

Researchers

Presenter

  • Chris J. Novotny

Principal Investigators

  • Sirkku Pollari

  • Jin H. Park

  • Mark A. Lemmon

  • Peter G. Schultz

  • Weijun Shen

  • Kevan M. Shokat

Medical Centers

  • University of California, San Francisco, San Francisco, CA

  • California Institute for Biomedical Research (Calibr), CA

  • University of Pennsylvania, PA.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Epidermal growth factor receptor

  • erb-b2 receptor tyrosine kinase 2

  • Erb-B2 Receptor Tyrosine Kinase 3

Drug/Treatment

  • Trastuzumab emtansine

  • Lapatinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved